Cargando…

Immune Responses to SARS-CoV-2 Vaccination in Young Patients with Anti-CD19 Chimeric Antigen Receptor T Cell-Induced B Cell Aplasia

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are capable of inducing combined humoral and cellular immunity. Which effect is more relevant for their potent protective effects is unclear, but isolated T cell responses without seroconversion in healthy household members of ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jarisch, Andrea, Wiercinska, Eliza, Huenecke, Sabine, Bremm, Melanie, Cappel, Claudia, Hauler, Julian, Rettinger, Eva, Soerensen, Jan, Hellstern, Helen, Klusmann, Jan-Henning, Ciesek, Sandra, Bonig, Halvard, Bader, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040419/ https://www.ncbi.nlm.nih.gov/pubmed/35472554 http://dx.doi.org/10.1016/j.jtct.2022.04.017

Ejemplares similares

In-vitro influence of mycophenolate mofetil (MMF) and Ciclosporin A (CsA) on cytokine induced killer (CIK) cell immunotherapy
por: Bremm, Melanie, et al.
Publicado: (2016)

Monitoring of Circulating CAR T Cells: Validation of a Flow Cytometric Assay, Cellular Kinetics, and Phenotype Analysis Following Tisagenlecleucel
por: Peinelt, Andreas, et al.
Publicado: (2022)

Adoptive cellular immunotherapy for refractory childhood cancers: a single center experience
por: Merker, Michael, et al.
Publicado: (2019)

Improving Clinical Manufacturing of IL-15 Activated Cytokine-Induced Killer (CIK) Cells
por: Bremm, Melanie, et al.
Publicado: (2019)

The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their ex vivo Expansion and Cytotoxic Potential Against Neuroblastoma: Perspective for Optimized Immunotherapy Post Haploidentical Stem Cell Transplantation
por: Heinze, Annekathrin, et al.
Publicado: (2019)

Development of Three Different NK Cell Subpopulations during Immune Reconstitution after Pediatric Allogeneic Hematopoietic Stem Cell Transplantation: Prognostic Markers in GvHD and Viral Infections
por: Huenecke, Sabine, et al.
Publicado: (2017)

SARS‐CoV‐2‐specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID‐19 vaccination
por: Jarisch, Andrea, et al.
Publicado: (2022)

Albumin Modifies Responses to Hematopoietic Stem Cell Mobilizing Agents in Mice
por: Danner, Eva, et al.
Publicado: (2019)

CD3/CD19 Depletion for T-cell Reduction of Allogeneic Transplants: Mostly Efficient, but not Robust
por: Wiercinska, Eliza, et al.
Publicado: (2021)

Validation of an ICH Q2 Compliant Flow Cytometry-Based Assay for the Assessment of the Inhibitory Potential of Mesenchymal Stromal Cells on T Cell Proliferation
por: Piede, Natascha, et al.
Publicado: (2023)

Allogeneic transplant procurement in the times of COVID-19: Quality report from the central European cryopreservation site
por: Wiercinska, Eliza, et al.
Publicado: (2021)

Retargeting of NK-92 Cells against High-Risk Rhabdomyosarcomas by Means of an ERBB2 (HER2/Neu)-Specific Chimeric Antigen Receptor
por: Gossel, Leonie D. H., et al.
Publicado: (2021)

Hematopoietic-Extrinsic Cues Dictate Circadian Redistribution of Mature and Immature Hematopoietic Cells in Blood and Spleen
por: Stenzinger, Miriam, et al.
Publicado: (2019)

Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma
por: Enßle, Julius C., et al.
Publicado: (2022)

An Exponential Regression Model Reveals the Continuous Development of B Cell Subpopulations Used as Reference Values in Children
por: Königs, Christoph, et al.
Publicado: (2018)

ErbB2 (HER2)-CAR-NK-92 cells for enhanced immunotherapy of metastatic fusion-driven alveolar rhabdomyosarcoma
por: Heim, Catrin, et al.
Publicado: (2023)

IL-2 Stimulated but Not Unstimulated NK Cells Induce Selective Disappearance of Peripheral Blood Cells: Concomitant Results to a Phase I/II Study
por: Brehm, Claudia, et al.
Publicado: (2011)

CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from Germany
por: Bader, Peter, et al.
Publicado: (2023)

ERBB2-CAR-Engineered Cytokine-Induced Killer Cells Exhibit Both CAR-Mediated and Innate Immunity Against High-Risk Rhabdomyosarcoma
por: Merker, Michael, et al.
Publicado: (2020)

Clinical Grade Purification and Expansion of NK Cell Products for an Optimized Manufacturing Protocol
por: Koehl, Ulrike, et al.
Publicado: (2013)

Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34(+)-Selected to CD3/CD19-Depleted Grafts in a Retrospective Multicenter Study
por: Salzmann-Manrique, Emilia, et al.
Publicado: (2018)

Generation and Characterization of Erythroid Cells from Human Embryonic Stem Cells and Induced Pluripotent Stem Cells: An Overview
por: Chang, Kai-Hsin, et al.
Publicado: (2011)

SMAC Mimetic BV6 Enables Sensitization of Resistant Tumor Cells but also Affects Cytokine-Induced Killer (CIK) Cells: A Potential Challenge for Combination Therapy
por: Rettinger, Eva, et al.
Publicado: (2014)

Co-culture of primary human T cells with leukemia cells to measure regulatory T cell expansion
por: Külp, Marius, et al.
Publicado: (2022)

Acquired Amegakaryocytic Thrombocytopenia and Pure Red Cell Aplasia in Thymoma
por: Dahal, Sumit, et al.
Publicado: (2018)

Myelodysplastic Syndrome with Erythroid Aplasia following Pure Red Cell Aplasia
por: Kim, Hyoung Doo, et al.
Publicado: (2004)

Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers—results of a dose escalation trial
por: Karpova, Darja, et al.
Publicado: (2017)

Emtricitabine-induced pure red cell aplasia
por: Manickchund, Nithendra, et al.
Publicado: (2019)

Automatic generation of alloreactivity-reduced donor lymphocytes and hematopoietic stem cells from the same mobilized apheresis product
por: Wiercinska, E., et al.
Publicado: (2023)

In vitro migration and proliferation (“wound healing”) potential of mesenchymal stromal cells generated from human CD271(+) bone marrow mononuclear cells
por: Latifi-Pupovci, Hatixhe, et al.
Publicado: (2015)

Biosimilar granulocyte–colony-stimulating factor for healthy donor stem cell mobilization: need we be afraid?
por: Bonig, Halvard, et al.
Publicado: (2015)

A New Perspective for Bone Tissue Engineering: Human Mesenchymal Stromal Cells Well-Survive Cryopreservation on β-TCP Scaffold and Show Increased Ability for Osteogenic Differentiation
por: Leppik, Liudmila, et al.
Publicado: (2022)

Treatment of Infantile Inflammatory Bowel Disease and Autoimmunity by Allogeneic Stem Cell Transplantation in LPS-Responsive Beige-Like Anchor Deficiency
por: Bakhtiar, Shahrzad, et al.
Publicado: (2017)

Pure red cell aplasia and associated thymoma
por: Rosu, Cristian, et al.
Publicado: (2011)

Lenalidomide-Induced Pure Red Cell Aplasia
por: Dolai, Tuphan Kanti, et al.
Publicado: (2014)

Pure White Cell Aplasia and Necrotizing Myositis
por: Kim, Peter Geon, et al.
Publicado: (2016)

B cell aplasia and hypogammaglobulinemia associated with levetiracetam
por: Ozdemir, Hulya, et al.
Publicado: (2018)

Erythropoietin‐induced pure red cell aplasia
por: Yeung, Vivian K. P.
Publicado: (2022)

Pure Red Cell Aplasia Associated With Thymoma
por: Thangatorai, Ramesh
Publicado: (2023)

PB2070: IMMUNE RESPONSES AFTER SARS-COV-2 MRNA-VACCINATION AND INFECTION AT SINGLE CELL RESOLUTION IN PATIENTS WITH MULTIPLE MYELOMA
por: Enssle, Julius C., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bv69moruq2ntpahh9qlgrdtt0t